Royal Bank of Canada
ZURA icon

Royal Bank of Canada’s Zura Bio ZURA Stock Holding History

Royal Bank of Canada’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,158
Closed -$11K – 7769
2025
Q4 		$11K Buy
2,158
+1,705
+376% +$6.74K ﹤0.01% 6387
2025
Q3 		$2K Buy
453
+176
+64% +$317 ﹤0.01% 6924
2025
Q2 		$0 Sell
277
-368
-57% -$440 ﹤0.01% 7401
2025
Q1 		$1K Sell
645
-366
-36% -$577 ﹤0.01% 6727
2024
Q4 		$3K Sell
1,011
-6,210
-86% -$22.1K ﹤0.01% 6673
2024
Q3 		$29K Buy
7,221
+5,339
+284% +$19.9K ﹤0.01% 5962
2024
Q2 		$7K Buy
+1,882
New +$7.67K ﹤0.01% 6462
2023
Q1 		– Sell
-13,944
Closed -$142K – 7565
2022
Q4 		$142K Sell
13,944
-25
-0.2% -$253 ﹤0.01% 5181
2022
Q3 		$140K Hold
13,969
– – ﹤0.01% 5070
2022
Q2 		$139K Sell
13,969
-1
-0% -$10 ﹤0.01% 5097
2022
Q1 		$138K Buy
+13,970
New +$138K ﹤0.01% 5407

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Royal Bank of Canada's ZURA Position: Q1 2026 in Review

Royal Bank of Canada sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 2,158 shares — an estimated $11K sold.

Royal Bank of Canada first reported a position in ZURA in Q1 2022 and held it in 11 quarters. The position peaked at $142K in Q4 2022. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Royal Bank of Canada reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 2,158 Zura Bio shares in Q1 2026, an estimated $11K.
  • Royal Bank of Canada first reported a position in Zura Bio in Q1 2022 and held it in 11 quarters.
  • Royal Bank of Canada's Zura Bio position peaked at $142K in Q4 2022.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.